Karl G Bjursell

Title: The Innovations of Karl G Bjursell

Introduction

Karl G Bjursell is a notable inventor based in Partille, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of DNA molecules that have important applications in medicine and nutrition.

Latest Patents

One of his key patents is related to genomic DNA sequences encoding human Bile Salt-Stimulated Lipase (BSSL) and Carboxyl Ester Lipase (CEL). This invention involves a DNA molecule that contains intron sequences and encodes a human protein. The DNA molecule is particularly useful in the production of recombinant human BSSL/CEL, which can be produced in transgenic non-human mammals. The recombinant human BSSL/CEL has potential applications in infant formulas as a substitute for human milk and in the manufacture of medicaments for conditions such as fat malabsorption, cystic fibrosis, and chronic pancreatitis. He holds 1 patent for this innovative work.

Career Highlights

Karl G Bjursell is associated with Aktiebolaget Astra, a prominent company in the pharmaceutical industry. His work at the company has allowed him to focus on groundbreaking research that bridges the gap between genetics and practical medical applications.

Collaborations

Throughout his career, Karl has collaborated with esteemed colleagues such as Peter N Carlsson and Curt S Enerback. These partnerships have fostered an environment of innovation and have contributed to the advancement of their shared research goals.

Conclusion

Karl G Bjursell's contributions to biotechnology and his innovative patent on genomic DNA sequences highlight his role as a significant inventor in the field. His work continues to impact medical and nutritional practices, showcasing the importance of research and development in improving human health.